From: Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab
Variable
Average IOP immediately after the Injection (mmHg)
Average MOPP immediately after the Injection (mmHg)
Post-injection vitreous regurgitation
Yes
39.92 ± 9.12
28.83 ± 9.56
No
44.68 ± 9.27
24.48 ± 8.27
p value
> 0.05